Market cap
$1,149 Mln
$2.46
As on 24-Apr-2026 13:41EDT
Market cap
$1,149 Mln
Revenue (TTM)
$1,924 Mln
P/E Ratio
--
P/B Ratio
3.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.3 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-0.6
Debt to Equity
--
Book Value
$0.6
EPS
$-0.2
Face value
--
Shares outstanding
428,951,430
CFO
$-917.51 Mln
EBITDA
$-1,460.44 Mln
Net Profit
$-1,674.92 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Clover Health Investments Corp. Class A (CLOV)
| 4.5 | 32.7 | -5.2 | -29.0 | 46.4 | -22.5 | -- |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Clover Health Investments Corp. Class A (CLOV)
| -25.4 | 227.6 | 2.4 | -75.0 | -77.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Clover Health Investments Corp. Class A (CLOV)
|
2.5 | 1,149.0 | 1,924.3 | -85.6 | -4.4 | -26.3 | -- | 3.7 |
| 21.0 | 4,335.2 | 3,948.7 | -0.7 | 0.4 | -0.5 | -- | 24.2 | |
| 41.2 | 18,771.0 | 194,777.0 | -6,673.0 | -3.3 | -28.8 | -- | 1.0 | |
| 273.2 | 73,825.6 | 274,952.0 | 5,957.0 | 3.4 | 14.4 | 12.5 | 1.7 | |
| 344.4 | 69,758.1 | 199,125.0 | 5,662.0 | 4.1 | 13.3 | 12.5 | 1.6 | |
| 212.9 | 23,905.7 | 129,664.0 | 1,188.0 | 1.6 | 7 | 20.2 | 1.3 | |
| 0.0 | 0.0 | 10.8 | -31.2 | -259.9 | 1164.6 | -- | 8.9 | |
| 173.2 | 7,760.0 | 45,426.0 | 472.0 | 1.7 | 11 | 16.7 | 1.9 | |
| 17.9 | 1,484.1 | 1,288.7 | 58.5 | 7.2 | 12.5 | 27.5 | 2.8 | |
| 352.6 | 278,574.8 | 447,567.0 | 12,056.0 | 4.2 | 12.9 | 23.2 | 3.0 |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant,... a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware. Read more
Co-Founder & Executive Chairman
Mr. Vivek Garipalli
Co-Founder & Executive Chairman
Mr. Vivek Garipalli
Headquarters
Wilmington, DE
Website
The share price of Clover Health Investments Corp Class A (CLOV) is $2.46 (NASDAQ) as of 24-Apr-2026 13:41 EDT. Clover Health Investments Corp Class A (CLOV) has given a return of 46.45% in the last 3 years.
Since, TTM earnings of Clover Health Investments Corp Class A (CLOV) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-14.06
|
3.90
|
|
2024
|
-35.89
|
4.52
|
|
2023
|
-2.15
|
1.60
|
|
2022
|
-1.30
|
1.24
|
|
2021
|
-2.61
|
2.87
|
The 52-week high and low of Clover Health Investments Corp Class A (CLOV) are Rs 3.92 and Rs 1.58 as of 25-Apr-2026.
Clover Health Investments Corp Class A (CLOV) has a market capitalisation of $ 1,149 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Clover Health Investments Corp Class A (CLOV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.